Anti-bone-drug test to help shoulder tendon healing after surgery
Part of Bones, joints & muscles, Injuries & trauma clinical trials.
This Phase 2 trial studies whether an anti-osteoporosis medicine (zoledronic acid) can improve healing after surgery for a chronic rotator cuff tear in the shoulder. If you qualify, you would also follow a specific 4-week physical therapy plan using a shoulder support pad.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 50 to 70 years
- Have an MRI-confirmed rotator cuff tear done within 6 months before surgery
- Your tear must be small (up to 3 cm at the biggest point)
- You must not be pregnant and must be willing to join the study
- Be willing to do a unified physical therapy plan for 4 weeks after surgery using a shoulder abduction pad
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether alendronate, a drug commonly used for bone health, can improve knee function and recovery after ACL surgery. It is for people having their first ACL repair.
This study tests whether a dissolvable implant that releases a medication called oxandrolone can improve recovery after ACL surgery. Oxandrolone may help strengthen the new ligament and speed up healing.
This study tests whether adding a concentrated bone marrow injection during repeat ACL surgery helps healing and recovery better than surgery alone. If you have had a previous ACL reconstruction that failed, you may be eligible.
This trial studies how well a Medacta shoulder replacement works by looking at clinical results and X-ray/scan findings after surgery. It may help people with certain shoulder conditions who need shoulder replacement or revision surgery.
This study checks how the body handles a medicine called zoledronic acid in people with kidney disease who are on dialysis and have weak bones (osteoporosis). It may help doctors find the right dose to safely treat bone loss in this group.
This trial tests a treatment using your own (autologous) regenerative cells to reduce pain and inflammation from shoulder osteoarthritis. It may help people with long-lasting shoulder pain, but you must meet several health and medication timing requirements.
Hear when a new Orthopedics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.